Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Journal: Genome medicine
Published: November 26, 2023
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Journal: Genome medicine
Published: March 08, 2019
Development of an adenovirus vector vaccine platform for targeting dendritic cells.
Journal: Cancer gene therapy
Published: July 03, 2017
Mammaglobin-A is a target for breast cancer vaccination.
Journal: Oncoimmunology
Published: July 01, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026